[Immunoprophylaxis and immunotherapy of infection caused by Pseudomonas aeruginosa: research results and prospects].
D000818:Animals; D000942:Antigens, Bacterial / Q000276:immunology; D000954:Antigens, Surface / Q000276:immunology; D001428:Bacterial Vaccines / Q000627:therapeutic use / Q000633:toxicity; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D006801:Humans; D007110:Immunity, Active; D007167:Immunotherapy; D008070:Lipopolysaccharides / Q000276:immunology; D011552:Pseudomonas Infections / Q000276:immunology / Q000517:prevention & control* / Q000628:therapy; D011550:Pseudomonas aeruginosa / Q000276:immunology / Q000472:pathogenicity; D012106:Research; D014121:Toxoids / Q000627:therapeutic use; D014774:Virulence
D000942:Antigens, Bacterial; D000954:Antigens, Surface; D001428:Bacterial Vaccines; D008070:Lipopolysaccharides; D014121:Toxoids
Immunoprofilaktika i immunoterapiia infektsii, vyzvannoĭ Pseudomonas aeruginosa: itogi i perspektivy issledovaniĭ.